Cited by 4,813

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

Open access

Locatelli, Francesco, Fishbane, Steven, Block, Geoffrey A., Macdougall, Iain C.·2017·American Journal of Nephrology

Open this paper in CoChat — free account

Abstract

Background: Anemia, a common complication of chronic kidney disease (CKD), has previously been attributed primarily to decreased production of erythropoietin. More recently, it has become apparent that the etiology of anemia involves several other factors, most notably dysfunctional iron metabolism, mediated via increased hepcidin activity and reduced clearance. Current management of anemia in patients with advanced CKD is based on erythropoiesis-stimulating agents and iron supplementation, along with red blood cell transfusions when necessary; however, safety considerations associated with these therapies highlight the need to pursue alternative treatment options targeting other mechanisms such as hypoxia-inducible factors (HIFs) that act as central regulators of erythropoiesis by coordinating a series of graded hypoxic responses. Summary: This review discusses the discovery of the HIF pathway and its regulation via HIF prolyl hydroxylase enzymes in the context of erythropoiesis and iron metabolism. The rationale for targeting this pathway and the clinical development of HIF prolyl hydroxylase inhibitors are reviewed, with a commentary on the potential implications of this class of agents in CKD anemia management. Key Messages: Pharmacologic activation of the HIF pathway results in a transient pseudo-hypoxic state that stimulates erythropoiesis in CKD patients with anemia. Results from clinical studies of a number of HIF prolyl hydroxylase inhibitors are increasingly available and provide support for the continued evaluation of the risk-benefit ratio of this novel therapeutic approach to the treatment of anemia in CKD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1159/000455166

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Anemia of Chronic Disease
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
Schödel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2011) · Blood · doi:10.1182/blood-2010-10-314427 · Cited by 724

Show all 19 references

Research works printed but not linked: 57

10.1681/ASN.2011111078 · DOI · Paper page
10.1001/jamainternmed.2013.13305 · DOI
10.1007/s11255-004-3068-2 · DOI
10.1097/MNH.0b013e328335f939 · DOI
10.1093/ndt/gfp546 · DOI
10.1038/kisup.2012.73 · DOI · Paper page
10.1056/NEJMoa062276 · DOI · Paper page
10.1053/j.ajkd.2012.07.014 · DOI
10.1093/ndt/gft033 · DOI
10.1681/ASN.2015060673 · DOI
10.1053/j.ajkd.2015.10.002 · DOI
10.1038/ki.2014.179 · DOI
10.1016/j.kint.2015.10.002 · DOI · Paper page
10.1038/ki.2014.275 · DOI
10.1136/pgmj.2006.049734 · DOI
10.1038/313806a0 · DOI · Paper page
10.1073/pnas.82.22.7580 · DOI · Paper page
10.1128/MCB.12.12.5447 · DOI · Paper page
10.1182/blood-2004-05-1695 · DOI
10.1096/fj.04-1640fje · DOI · Paper page
10.1038/kisup.2014.6 · DOI
10.1681/ASN.2013010030 · DOI
10.1681/ASN.2014121184 · DOI
10.1038/28867 · DOI · Paper page
10.1016/S0002-9440(10)64554-3 · DOI · Paper page
10.1016/j.blre.2012.12.003 · DOI · Paper page
10.1096/fj.02-1062fje · DOI
10.1038/ki.2010.326 · DOI
10.1159/000148256 · DOI
10.1172/JCI74997 · DOI
10.1016/j.stem.2010.06.020 · DOI · Paper page
10.1182/blood-2012-02-408419 · DOI
10.1152/ajprenal.00736.2009 · DOI
10.1128/MCB.00161-15 · DOI
10.1172/JCI15686 · DOI · Paper page
10.1111/1744-9987.12001 · DOI
10.1182/blood-2014-06-584607 · DOI · Paper page
10.1073/pnas.88.19.8725 · DOI
10.1007/BF01836070 · DOI
10.2215/CJN.05931108 · DOI
10.1016/j.cmet.2011.08.015 · DOI · Paper page
10.1016/j.bbagen.2013.08.012 · DOI
10.1002/biof.1148 · DOI
10.1038/nrc3627 · DOI · Paper page
10.1177/1947601911423654 · DOI · Paper page
10.1007/s11906-001-0086-7 · DOI
10.1371/journal.pone.0111838 · DOI
10.13140/RG.2.2.25981.36327 · DOI
10.1007/s10928-007-9074-0 · DOI
10.1093/ndt/gfv302 · DOI · Paper page
10.1681/ASN.2015030241 · DOI
10.2215/CJN.06890615 · DOI · Paper page
10.1053/j.ajkd.2015.12.020 · DOI · Paper page
10.1016/j.kint.2016.07.019 · DOI
10.1053/j.ajkd.2015.11.021 · DOI
10.1681/ASN.2014111139 · DOI
10.1111/bph.13188 · DOI

Items 201–273 of 273

Non-Invasive Tumor Genotyping Using Radiogenomic Biomarkers, a Systematic Review and Oncology-Wide Pathway Analysis
Jansen, R. W., van Amstel, P., Martens, R. M., Kooi, I. E., Wesseling, P., de Langen, A. J., Menke-Van der Houven van Oordt, C. W., Jansen, B. H. E., Moll, A. C., Dorsman, J. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24893 · Cited by 63
Effects of an acute exercise bout on serum hepcidin levels
Domínguez, R., Sánchez-Oliver, A., Mata-Ordoñez, F., Feria-Madueño, A., Grimaldi-Puyana, M., López-Samanes, Á., & Pérez-López, A. (2018) · Nutrients · doi:10.3390/nu10020209 · Cited by 64
Transcriptome Analysis of Circulating PBMCs to Understand Mechanism of High Altitude Adaptation in Native Cattle of Ladakh Region
Verma, P., Sharma, A., Sodhi, M., Thakur, K., Kataria, R. S., Niranjan, S. K., Bharti, V. K., Kumar, P., Giri, A., Kalia, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25736-7 · Cited by 63
The oxygen sensing signal cascade under the influence of reactive oxygen species
Acker, H. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1760 · Cited by 63
Reticular dysgenesis–associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress
Rissone, A., Weinacht, K. G., la Marca, G., Bishop, K., Giocaliere, E., Jagadeesh, J., Felgentreff, K., Dobbs, K., Al-Herz, W., Jones, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141286 · Cited by 63
A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin
Tolonen, J.-P., Heikkilä, M., Malinen, M., Lee, H.-M., Palvimo, J. J., Wei, G.-H., & Myllyharju, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03387-9 · Cited by 63
Adipose tissue aging is regulated by an altered immune system
Zhang, Y.-X., Ou, M.-Y., Yang, Z.-H., Sun, Y., Li, Q.-F., & Zhou, S.-B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125395 · Cited by 62
Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control
Cheng, X., Prange-Barczynska, M., Fielding, J. W., Zhang, M., Burrell, A. L., Lima, J. D. C. C., Eckardt, L., Argles, I. L. A., Pugh, C. W., Buckler, K. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133194 · Cited by 62
Prognostic role of hypoxia-inducible factor-2α tumor cell expression in cancer patients: a meta-analysis
Moreno Roig, E., Yaromina, A., Houben, R., Groot, A. J., Dubois, L., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00224 · Cited by 60
Duodenal HFE expression and hepcidin levels determine body iron homeostasis: modulation by genetic diversity and dietary iron availability
Ludwiczek, S., Theurl, I., Artner-Dworzak, E., Chorney, M., & Weiss, G. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0542-3 · Cited by 57
Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor
Renfrow, J. J., Soike, M. H., West, J. L., Ramkissoon, S. H., Metheny-Barlow, L., Mott, R. T., Kittel, C. A., D’Agostino, R. B., Tatter, S. B., Laxton, A. W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72290-2 · Cited by 45
Epidermal hepcidin is required for neutrophil response to bacterial infection
Malerba, M., Louis, S., Cuvellier, S., Shambat, S. M., Hua, C., Gomart, C., Fouet, A., Ortonne, N., Decousser, J.-W., Zinkernagel, A. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126645 · Cited by 55
The hypoxia‐induced changes in miRNA‐mRNA in RNA ‐induced silencing complexes and HIF ‐2 induced miRNAs in human endothelial cells
Moszyńska, A., Jaśkiewicz, M., Serocki, M., Cabaj, A., Crossman, D. K., Bartoszewska, S., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2022) · The FASEB Journal · doi:10.1096/fj.202101987r · Cited by 53
VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop
Boudria, A., Abou Faycal, C., Jia, T., Gout, S., Keramidas, M., Didier, C., Lemaître, N., Manet, S., Coll, J.-L., Toffart, A.-C., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0486-7 · Cited by 53
Pre-clinical Models of Metastasis in Pancreatic Cancer
Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53
Twelve weeks of supervised exercise improves self-reported symptom burden and fatigue in chronic kidney disease: a secondary analysis of the ‘ExTra CKD’ trial
Wilkinson, T. J., Watson, E. L., Gould, D. W., Xenophontos, S., Clarke, A. L., Vogt, B. P., Viana, J. L., & Smith, A. C. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfy071 · Cited by 52
Identification of oleoylethanolamide as an endogenous ligand for HIF-3α
Diao, X., Ye, F., Zhang, M., Ren, X., Tian, X., Lu, J., Sun, X., Hou, Z., Chen, X., Li, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30338-z · Cited by 51
Iron Metabolism: Interactions with Energy and Carbohydrate Availability
McKay, A. K. A., Pyne, D. B., Burke, L. M., & Peeling, P. (2020) · Nutrients · doi:10.3390/nu12123692 · Cited by 51
Iron Loading Increases Ferroportin Heterogeneous Nuclear RNA and mRNA Levels in Murine J774 Macrophages
Aydemir, F., Jenkitkasemwong, S., Gulec, S., & Knutson, M. D. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.094052 · Cited by 49
Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
Ramsey, J. M., Cooper, J. D., Penninx, B. W. J. H., & Bahn, S. (2016) · Scientific Reports · doi:10.1038/srep26947 · Cited by 45
The force is strong with this one: metabolism (Over)powers stem cell fate
Wei, P., Dove, K. K., Bensard, C., Schell, J. C., & Rutter, J. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.007 · Cited by 47
Vascular growth factors in neuropsychiatry
Newton, S. S., Fournier, N. M., & Duman, R. S. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1281-9 · Cited by 48
Heightening Energetic Stress Selectively Targets LKB1-Deficient Non–Small Cell Lung Cancers
Momcilovic, M., McMickle, R., Abt, E., Seki, A., Simko, S. A., Magyar, C., Stout, D. B., Fishbein, M. C., Walser, T. C., Dubinett, S. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0797 · Cited by 46
Patient-specific organotypic blood vessels as an in vitro model for anti-angiogenic drug response testing in renal cell carcinoma
Jiménez-Torres, J. A., Virumbrales-Muñoz, M., Sung, K. E., Lee, M. H., Abel, E. J., & Beebe, D. J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.026 · Cited by 46
Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans
Darton, T. C., Blohmke, C. J., Giannoulatou, E., Waddington, C. S., Jones, C., Sturges, P., Webster, C., Drakesmith, H., Pollard, A. J., & Armitage, A. E. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004029 · Cited by 45
Adaptive Exhaustion during Prolonged Intermittent Hypoxia Causes Dysregulated Skeletal Muscle Protein Homeostasis
Attaway, A. H., Bellar, A., Mishra, S., Karthikeyan, M., Sekar, J., Welch, N., Musich, R., Singh, S. S., Kumar, A., Menon, A., et al. (2023) · The Journal of Physiology · doi:10.1113/jp283700 · Cited by 45
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody
Park, J. A., Espinosa-Cotton, M., Guo, H.-F., Monette, S., & Cheung, N.-K. V. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006680 · Cited by 46
Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors
Casillas, A. L., Chauhan, S. S., Toth, R. K., Sainz, A. G., Clements, A. N., Jensen, C. C., Langlais, P. R., Miranti, C. K., Cress, A. E., & Warfel, N. A. (2021) · Oncogene · doi:10.1038/s41388-021-01915-1 · Cited by 44
Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo.
(2017) · Europe PMC (PubMed Central) · Cited by 44
The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment
Bartoszewska, S., Collawn, J. F., & Bartoszewski, R. (2022) · Cancers · doi:10.3390/cancers14194870 · Cited by 43
Role of Hypoxia and HIF2α in Development of the Sympathoadrenal Cell Lineage and Chromaffin Cell Tumors with Distinct Catecholamine Phenotypic Features
Richter, S., Qin, N., Pacak, K., & Eisenhofer, G. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00014-2 · Cited by 42
Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate
Hait, N. C., Maiti, A., Xu, P., Qi, Q., Kawaguchi, T., Okano, M., Takabe, K., Yan, L., & Luo, C. (2020) · The FASEB Journal · doi:10.1096/fj.201901734rr · Cited by 41
Hypoxia-inducible factor 2α: a novel target in gliomas
Renfrow, J. J., Soike, M. H., Debinski, W., Ramkissoon, S. H., Mott, R. T., Frenkel, M. B., Sarkaria, J. N., Lesser, G. J., & Strowd, R. E. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0163 · Cited by 40
Oxygen levels regulate the development of human cortical radial glia cells
Ortega, J. A., Sirois, C. L., Memi, F., Glidden, N., & Zecevic, N. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw194 · Cited by 37
Perspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Y., Coleman, M., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13123070 · Cited by 39
Pharmacologic ascorbate (P-AscH−) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma
Wilkes, J. G., O’Leary, B. R., Du, J., Klinger, A. R., Sibenaller, Z. A., Doskey, C. M., Gibson-Corley, K. N., Alexander, M. S., Tsai, S., Buettner, G. R., et al. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9876-z · Cited by 36
Iron metabolism in critically ill patients developing anemia of inflammation: a case control study
Boshuizen, M., Binnekade, J. M., Nota, B., van de Groep, K., Cremer, O. L., Tuinman, P. R., Horn, J., Schultz, M. J., van Bruggen, R., Juffermans, N. P., et al. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0407-5 · Cited by 39
Mimicking Embedded Vasculature Structure for 3D Cancer on a Chip Approaches through Micromilling
Wan, L., Skoko, J., Yu, J., Ozdoganlar, O. B., LeDuc, P. R., & Neumann, C. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-16458-3 · Cited by 38
Senp1 drives hypoxia-induced polycythemia via GATA1 and Bcl-xL in subjects with Monge's disease
Azad, P., Zhao, H. W., Cabrales, P. J., Ronen, R., Zhou, D., Poulsen, O., Appenzeller, O., Hsiao, Y. H., Bafna, V., & Haddad, G. G. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151920 · Cited by 38
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
Pang, Y., Yang, C., Schovanek, J., Wang, H., Bullova, P., Caisova, V., Gupta, G., Wolf, K. I., Semenza, G. L., Zhuang, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16224 · Cited by 37
Micro RNA s regulate T‐cell production of interleukin‐9 and identify hypoxia‐inducible factor‐2 α as an important regulator of T helper 9 and regulatory T‐cell differentiation
Singh, Y., Garden, O. A., Lang, F., & Cobb, B. S. (2016) · Immunology · doi:10.1111/imm.12631 · Cited by 37
Fractalkine Induces Hepcidin Expression of BV-2 Microglia and Causes Iron Accumulation in SH-SY5Y Cells
Pandur, E., Tamási, K., Pap, R., Varga, E., Miseta, A., & Sipos, K. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00694-4 · Cited by 37
Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation
Tanno, T., Rabel, A., Lee, Y. T., Yau, Y. Y., Leitman, S. F., & Miller, J. L. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02601.x · Cited by 34
HIF1α stabilization in hypoxia is not oxidant-initiated
Kumar, A., Vaish, M., Karuppagounder, S. S., Gazaryan, I., Cave, J. W., Starkov, A. A., Anderson, E. T., Zhang, S., Pinto, J. T., Rountree, A. M., et al. (2021) · eLife · doi:10.7554/elife.72873 · Cited by 34
Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction
Ross, S. L., Biswas, K., Rottman, J., Allen, J. R., Long, J., Miranda, L. P., Winters, A., & Arvedson, T. L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00838 · Cited by 33
Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice
Thomas, A., Belaidi, E., Aron-Wisnewsky, J., van der Zon, G. C., Levy, P., Clement, K., Pepin, J.-L., Godin-Ribuot, D., & Guigas, B. (2016) · Scientific Reports · doi:10.1038/srep24618 · Cited by 33
Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
Lappano, R., Todd, L. A., Stanic, M., Cai, Q., Maggiolini, M., Marincola, F., & Pietrobon, V. (2022) · Cancers · doi:10.3390/cancers14030539 · Cited by 32
Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-Analysis
Fan, Y., Li, H., Ma, X., Gao, Y., Chen, L., Li, X., Bao, X., Du, Q., Zhang, Y., & Zhang, X. (2015) · Medicine · doi:10.1097/md.0000000000001646 · Cited by 32
Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation
ABD-AZIZ, N., STANBRIDGE, E. J., & SHAFEE, N. (2015) · Oncology Letters · doi:10.3892/ol.2015.3545 · Cited by 31
Mitochondrial Dysfunction Inhibits Hypoxia-Induced HIF-1α Stabilization and Expression of Its Downstream Targets
van Gisbergen, M. W., Offermans, K., Voets, A. M., Lieuwes, N. G., Biemans, R., Hoffmann, R. F., Dubois, L. J., & Lambin, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00770 · Cited by 30
Coordination of hypoxia adaptation and iron homeostasis in human pathogenic fungi
Chung, D., Haas, H., & Cramer, R. A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00381 · Cited by 29
Erythropoietin signaling in peripheral macrophages is required for systemic β‐amyloid clearance
Xu, L., Li, L., Pan, C., Song, J., Zhang, C., Wu, X., Hu, F., Liu, X., Zhang, Z., & Zhang, Z. (2022) · The EMBO Journal · doi:10.15252/embj.2022111038 · Cited by 29
Impact of high-altitude hypoxia on bone defect repair: A review of molecular mechanisms and therapeutic implications
Chen, P., Liu, Y., Liu, W., Wang, Y., Liu, Z., & Rong, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.842800 · Cited by 29
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
Fu, C., Tyagi, R., Chin, A. C., Rojas, T., Li, R.-J., Guha, P., Bernstein, I. A., Rao, F., Xu, R., Cha, J. Y., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311983 · Cited by 28
Multiple Faces of the Glioblastoma Microenvironment
Șovrea, A. S., Boșca, B., Melincovici, C. S., Constantin, A.-M., Crintea, A., Mărginean, M., Dronca, E., Jianu, M. E., Suflețel, R., Gonciar, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020595 · Cited by 26
Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis
Kelleher, T., Ryan, E., Barrett, S., Sweeney, M., Byrnes, V, O’Keane, C., & Crowe, J. (2004) · Gut · doi:10.1136/gut.2003.033811 · Cited by 24
Metabolic reprogramming of the inflammatory response in the nervous system: the crossover between inflammation and metabolism
Amo-Aparicio, J., Dinarello, C. A., & Lopez-Vales, R. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.391330 · Cited by 25
Mutant IDH : A Targetable Driver of Leukemic Phenotypes Linking Metabolism, Epigenetics and Transcriptional Regulation
Garrett-Bakelman, F. E., & Melnick, A. M. (2016) · Epigenomics · doi:10.2217/epi-2016-0008 · Cited by 25
A New Method to Improve Running Economy and Maximal Aerobic Power in Athletes: Endurance Training With Periodic Carbon Monoxide Inhalation
Wang, J., Ji, Y., Zhou, L., Xiang, Y., Heinonen, I., & Zhang, P. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00701 · Cited by 22
Sigma-2 Receptors Play a Role in Cellular Metabolism: Stimulation of Glycolytic Hallmarks by CM764 in Human SK-N-SH Neuroblastoma
Nicholson, H., Mesangeau, C., McCurdy, C. R., & Bowen, W. D. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.228387 · Cited by 22
Relationship of iron metabolism and short-term cuprizone treatment of c57bl/6 mice
Pandur, E., Pap, R., Varga, E., Jánosa, G., Komoly, S., Fórizs, J., & Sipos, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092257 · Cited by 21
Induced Disruption of the Iron-Regulatory Hormone Hepcidin Inhibits Acute Inflammatory Hypoferraemia
Armitage, A. E., Lim, P. J., Frost, J. N., Pasricha, S.-R., Soilleux, E. J., Evans, E., Morovat, A., Santos, A., Diaz, R., Biggs, D., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000447713 · Cited by 20
The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma
Wang, Y., Liu, B., Li, F., Zhang, Y., Gao, X., Wang, Y., & Zhou, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1274239 · Cited by 18
Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells
Li, F., & Cui, J. (2015) · Medical Oncology · doi:10.1007/s12032-015-0649-0 · Cited by 18
Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow Niche
Maynard, R. S., Hellmich, C., Bowles, K. M., & Rushworth, S. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924567 · Cited by 17
Quiescence of adult oligodendrocyte precursor cells requires thyroid hormone and hypoxia to activate Runx1
Tokumoto, Y., Tamaki, S., Kabe, Y., Takubo, K., & Suematsu, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01023-9 · Cited by 16
PU.1 is required to restrain myelopoiesis during chronic inflammatory stress
Chavez, J. S., Rabe, J. L., Niño, K. E., Wells, H. H., Gessner, R. L., Mills, T. S., Hernandez, G., & Pietras, E. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1204160 · Cited by 14
HIF-2α Preserves Mitochondrial Activity and Glucose Sensing in Compensating β-Cells in Obesity
Moon, J.-S., Riopel, M., Seo, J. B., Herrero-Aguayo, V., Isaac, R., & Lee, Y. S. (2022) · Diabetes · doi:10.2337/db21-0736 · Cited by 13
Associations between HIFs and tumor immune checkpoints: mechanism and therapy
Liu, J., Jiang, Y., Chen, L., Qian, Z., & Zhang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-023-00836-7 · Cited by 13
Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies
Harlow, C. E., Gandawijaya, J., Bamford, R. A., Martin, E.-R., Wood, A. R., van der Most, P. J., Tanaka, T., Leonard, H. L., Etheridge, A. S., Innocenti, F., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.08.004 · Cited by 13
Dietary and Sentinel Factors Leading to Hemochromatosis
Oh, C.-K., & Moon, Y. (2019) · Nutrients · doi:10.3390/nu11051047 · Cited by 12
Modeling the dynamics of mouse iron body distribution: hepcidin is necessary but not sufficient
Parmar, J. H., Davis, G., Shevchuk, H., & Mendes, P. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0431-3 · Cited by 12
HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma
Contenti, J., Guo, Y., Larcher, M., Mirabal-Ortega, L., Rouleau, M., Irondelle, M., Tiroille, V., Mazzu, A., Duranton-Tanneur, V., Pedeutour, F., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02100-5 · Cited by 6

Authors: Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C.
Venue: American Journal of Nephrology
Publisher: S. Karger AG
Published: 2017
Volume: 45
Issue: 3
Pages: 187-199
ISSN: 0250-8095 (ISSN-L)
1421-9670
DOI: 10.1159/000455166
OpenAlex: W2580449060
Cited by: 4,813
References: 19
FWCI: 270.17
Type: journal article
Language: en
Open access: hybrid
Licence: creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources